-
Drug Maker In Pressure: Merck & Co., Inc. (NYSE:MRK) Face Lawsuit of $100 million
A sales person for Merck & Co., Inc. (NYSE:MRK) filed court case of overi$100M sex discrimination against the drugmaker, asserting that it mainly distinguishes alongside pregnant employees and women among children. In a claim filed in U.S. District Court in New Jersey, the claimant, Kelli Smith asserts she was downgraded for taking maternity leave in…
-
Pharmaceutical Stocks In Hot List: Pfizer Inc. (NYSE:PFE), Eli Lilly & Co. (NYSE:LLY)
Big healthcare sector firms Pfizer Inc. (NYSE:PFE) and Eli Lilly & Co. (NYSE:LLY) are plans to post its fourth quarter results before the open on Tuesday, Jan 29, 2013 as both firms endure to manage their post-blockbuster decrease. According to the analysts polled by Thomson Reuters,anticipate Pfizer (PFE) to declared profit of 44 cents per…
-
Sprint Nextel (NYSE:S) has three More News other than the Latest Deal – (CLWR, ANR, BMY, T)
Wall Street marked strong rally Monday as investors digested upbeat retail sales data and higher-than-projected earnings from Citigroup that helped boost the financial sector. Sprint Nextel Corporation (NYSE:S) is the most active stock in the stock market these days as is set to sell its majority stake to Japanese Softbank. The deal was considered this…
-
Report: Cancer Replaces Heart Disease As No.1 Killer – (PFE, BMY, JNJ, MRK)
Cancer has surpassed heart disease as the leading cause of death among Hispanics in the U.S., likely revealing the large number of young, working-age Hispanics in America, according to a report released by the American Cancer Society Monday. Cancer society researchers performed study on federal death data for 2009 and concluded that 29,935 Hispanics died…
-
NIH Clinical Center in Maryland Declares Seventh Death from a Deadly Germ – (PFE, MRK, JNJ, BMY)
A deadly germ that was not treatable by the majority antibiotics has caused death of a seventh person at the National Institutes of Health Clinical Center in Maryland. The Washington Post declared about the death on Friday. NIH representatives told media that the boy from Minnesota died September 7. NIH told that the boy was…
-
7 Stocks On The Move After News – (NEXS, PLL, ANR, PEIX, SNSS, VICL, MKTS)
Nexxus Lighting, Inc. (NASDAQ:NEXS) gained about 250% on Thursday after declaring that an affiliate of the investor Aston Capital, LLC has decided to spend $6 million in the Company through the acquisition of convertible preferred stock in order to provide strategic, operational and financial expertise with an aim to enable the Company’s strategic growth and…
-
Two Studies Reveal Bapineuzumab Also Have Some Potential Benefit – (PFE, JNJ, MRK, BMY)
Complete results of two important studies, one led by Dr. Reisa Sperling and other led by Dr. Stephen Salloway, now reveal that an experimental drug that was unable to stop mental decline in Alzheimer’s patients also disclosed some potential benefit. Researchers reported today a number of patients on the drug had gained stable levels of…
-
A Study Finds Using Steroids Can Delay Growth, But Not Greatly – (MRK, PFE, JNJ, BMY)
Adults who used inhaled steroids as children in order to get control over their asthma may be shorter than they otherwise would have been, but only by a little, according to U.S. researchers. Results, released on Monday, of a long-term asthma study concluded that children who took inhaled steroids before they entered puberty were around…
-
Major Pharma Companies Sustain Revenue Growth In Promising Markets – (PFE, LLY, BMY, JNJ)
Major pharma companies across the universe such as Pfizer Inc. (NYSE:PFE) and recent top price hitter Eli Lilly & Co. (NYSE:LLY) continue to generate higher revenue from sales in promising market countries. For Pfizer, rising market sales moved up in the second quarter of fiscal 2012 to $2.6 billion. Over the similar quarter, Eli Lily…
-
Pfizer Inc. (NYSE:PFE) Settles DOJ And SEC Issues – (BMY, JNJ, MRK)
While hospital and insurer executives looked-for an important Supreme Court decision on the future of President Barack Obama’s health-care overhaul bill, two of the hedge fund gurus including David Einhorn and Daniel Loeb were confident that the legislation would be overturned, documents suggest. Pfizer Inc. (NYSE:PFE) plans to add an over-the-counter version of AstraZeneca (AZN)…